Antibody-based inhibitors of HIV infection

The demand for new treatment options against HIV is becoming increasingly desperate as the side effects and the expansion and spread of drug-resistant virus within the infected population limit the clinical benefits provided by available anti-HIV drugs. Preparations of polyclonal antibodies have a l...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Expert opinion on biological therapy 2006-05, Vol.6 (5), p.523-531
Hauptverfasser:	Choudhry, Vidita, Zhang, Mei-Yun, Dimitrova, Dimana, Prabakaran, Ponraj, Dimitrov, Antony S, Fouts, Timothy R, Dimitrov, Dimiter S
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals antibody therapeutics CD4 Antigens - genetics CD4 Antigens - immunology Clinical Trials as Topic envelope glycoprotein fusion HIV HIV Antibodies - immunology HIV Antibodies - therapeutic use HIV Envelope Protein gp120 - immunology HIV Envelope Protein gp41 - immunology HIV Infections - therapy HIV-1 - immunology Human immunodeficiency virus Humans Immunotherapy - trends neutralisation Receptors, CCR5 - immunology vaccine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!